Literature DB >> 2614237

Role and results of cortical mastoidectomy and endolymphatic sac surgery in Menière's disease.

A G Kerr1, J G Toner, G J McKee, G D Smyth.   

Abstract

It is almost impossible to establish the natural history of Menière's disease and, by the same token, it is difficult to confirm the efficacy of endolymphatic sac surgery. The authors doubt the logic of sac operations. Only two controlled trials of sac surgery have been found and both cast doubt upon its value. There do not appear to be any controlled trials indicating that it works. In 14 cases of incapacitating Menière's disease, where vestibular nerve section was indicated, cortical mastoidectomy was offered and accepted in the expectation that two-thirds might be spared the more major procedure. In the event, the vertigo was controlled in eight out of 14 (57 per cent), the remaining six (43 per cent) requiring more major surgery. A surgical model illustrates that, of themselves, these results are essentially meaningless in assessing the efficacy of cortical mastoidectomy in Menière's disease. Until all cases in a community are considered and followed-up, we shall be in doubt about the value of sac surgery and most other treatments of Menière's disease.

Entities:  

Mesh:

Year:  1989        PMID: 2614237     DOI: 10.1017/s0022215100111272

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  3 in total

1.  Procedures for restoring vestibular disorders.

Authors:  Leif Erik Walther
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2005-09-28

2.  Aspects of vertigo.

Authors:  A G Kerr
Journal:  J R Soc Med       Date:  1990-06       Impact factor: 18.000

3.  miR-4711-5p regulates cancer stemness and cell cycle progression via KLF5, MDM2 and TFDP1 in colon cancer cells.

Authors:  Yoshihiro Morimoto; Tsunekazu Mizushima; Xin Wu; Daisuke Okuzaki; Yuhki Yokoyama; Akira Inoue; Tsuyoshi Hata; Haruka Hirose; Yamin Qian; Jiaqi Wang; Norikatsu Miyoshi; Hidekazu Takahashi; Naotsugu Haraguchi; Chu Matsuda; Yuichiro Doki; Masaki Mori; Hirofumi Yamamoto
Journal:  Br J Cancer       Date:  2020-02-18       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.